Vaccines

Investigators in the Vanderbilt Vaccine Center are developing and testing new vaccines for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV), the most common causes of wheezing and pneumonia in children. We have developed several experimental vaccines that are in preclinical development stages, moving toward clinical trials.

  • Alphavirus-vectored RSV Vaccine

  • Computationally Designed RSV Vaccine

 

Immunology

  • Allergy/Asthma

  • HIV/AIDS

  • Immune Repertoires

  • Transplantation

 

Viruses

  • Chikungunya Virus

  • ​Dengue Virus

  • Ebola and Marburg Viruses

  • Hantavirus

  • HIV/AIDS

  • Human Metapneumovirus

  • ​Influenza VIrus

  • Japanese Encephalitis Virus

  • Measles Virus

  • Norovirus

  • Paraininfluenza Virus Type 3

  • Poxviruses (Smallpox, Monkeypox, Cowpox, Vaccinia)

  • Rabies Virus

  • Respiratory Syncytial Virus (RSV)

  • Rift Valley Fever Virus

  • Rotavirus

 

Bacteria

  • Staphylococcus Aureus

  • ​Bordetella Pertussis

 

 

Collaborative Research Locations